Cue Biopharma Inc
(CUE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,701 | 27,492 | 13,136 | 22,459 | 32,420 |
| Marketable Securities | 8,718 | 470 | 912 | 929 | N/A |
| Receivables | 387 | 532 | N/A | 945 | 3,152 |
| Other current assets | 1,899 | 0 | 0 | 0 | 0 |
| TOTAL | $25,819 | $30,844 | $15,931 | $25,138 | $37,256 |
| Non-Current Assets | |||||
| PPE Net | 307 | 454 | 523 | 471 | 570 |
| Other Non-Current Assets | 5,518 | 9,409 | 5,800 | 6,582 | 6,984 |
| TOTAL | $5,825 | $9,863 | $6,323 | $7,053 | $7,554 |
| Total Assets | $31,644 | $40,707 | $22,254 | $32,191 | $44,810 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,458 | 2,416 | 3,374 | 4,333 | 3,963 |
| Accounts payable and accrued liabilities | 2,348 | 3,627 | 4,319 | 2,823 | 6,474 |
| Accrued Expenses | 1,871 | 1,518 | 4,230 | 2,908 | 3,199 |
| Other current liabilities | 7,816 | 9,579 | N/A | 85 | 259 |
| TOTAL | $15,524 | $19,254 | $15,498 | $13,689 | $16,790 |
| Non-Current Liabilities | |||||
| Long Term Debt | 190 | 190 | N/A | N/A | 1,328 |
| Other Non-Current Liabilities | 2,684 | 3,104 | 176 | 1,003 | 1,326 |
| TOTAL | $2,874 | $3,294 | $176 | $1,003 | $2,654 |
| Total Liabilities | $18,398 | $22,548 | $15,674 | $14,692 | $19,444 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,738 | 76,846 | 75,350 | 61,819 | 63,350 |
| Common Shares | 78 | 76 | 62 | 62 | 60 |
| Retained earnings | -370,051 | -362,603 | -354,121 | -341,864 | -332,368 |
| Other shareholders' equity | 1 | 0 | 0 | 0 | 0 |
| TOTAL | $13,246 | $18,159 | $6,580 | $17,499 | $25,366 |
| Total Liabilities And Equity | $31,644 | $40,707 | $22,254 | $32,191 | $44,810 |